Scarica l'app Stockscreener
1.09
3.54%
-0.04
Precedente Chiudi:
$1.13
Aprire:
$1.13
Volume 24 ore:
216.91K
Relative Volume:
0.76
Capitalizzazione di mercato:
$97.78M
Reddito:
-
Utile/perdita netta:
$-30.15M
Rapporto P/E:
-1.1978
EPS:
-0.91
Flusso di cassa netto:
$-31.63M
1 W Prestazione:
-13.49%
1M Prestazione:
+12.51%
6M Prestazione:
+25.72%
1 anno Prestazione:
-50.00%
Intervallo 1D:
$1.052
$1.15
Intervallo di 1 settimana:
$1.052
$1.34
Portata 52W:
$0.49
$2.3257
Context Therapeutics Inc Stock (CNTX) Company Profile
Nome
Context Therapeutics Inc
Settore
Industria
Telefono
267-225-7416
Indirizzo
2001 MARKET STREET, PHILADELPHIA
Confronta CNTX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CNTX
Context Therapeutics Inc
|
1.09 | 101.37M | 0 | -30.15M | -31.63M | -0.91 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | -52.09M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Context Therapeutics Inc Stock (CNTX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-18 | Iniziato | Guggenheim | Buy |
| 2025-04-21 | Iniziato | William Blair | Outperform |
| 2025-01-08 | Iniziato | JMP Securities | Mkt Outperform |
| 2024-11-25 | Iniziato | D. Boral Capital | Buy |
| 2024-05-16 | Iniziato | Piper Sandler | Overweight |
Context Therapeutics Inc Borsa (CNTX) Ultime notizie
Is Context Therapeutics Inc. stock positioned well for digital economyJuly 2025 Summary & Scalable Portfolio Growth Methods - newser.com
Is Context Therapeutics Inc. a candidate for recovery playBond Market & Fast Entry and Exit Trade Plans - newser.com
Is Context Therapeutics Inc. trending in predictive chart modelsPortfolio Update Summary & Daily Stock Trend Watchlist - newser.com
Real time scanner hits for Context Therapeutics Inc. explained2025 Technical Patterns & Real-Time Volume Analysis Alerts - newser.com
Context Therapeutics Inc. stock trendline breakdown2025 Earnings Impact & Weekly High Potential Stock Alerts - newser.com
What’s the recovery path for long term holders of Context Therapeutics Inc.Trade Performance Summary & Precise Swing Trade Alerts - newser.com
Is Context Therapeutics Inc. stock a top pick in earnings seasonNew Guidance & Breakout Confirmation Trade Signals - newser.com
What recovery options are there for Context Therapeutics Inc.Portfolio Gains Report & Comprehensive Market Scan Reports - newser.com
Is Context Therapeutics Inc. stock resilient to inflationWeekly Trade Analysis & Fast Exit and Entry Strategy Plans - newser.com
Context Therapeutics Grants Stock Options to New Hire - MSN
How to interpret RSI for Context Therapeutics Inc. stockM&A Rumor & Weekly High Conviction Ideas - newser.com
Does Context Therapeutics Inc. stock trade at a discount to peersPortfolio Return Summary & Safe Entry Zone Identification - newser.com
Applying chart zones and confluence areas to Context Therapeutics Inc.2025 Price Action Summary & Consistent Profit Focused Trading Strategies - newser.com
Is Context Therapeutics Inc. stock a defensive play in 2025July 2025 Retail & AI Forecasted Entry and Exit Points - newser.com
Why hedge funds are buying Context Therapeutics Inc. stockEarnings Recap Summary & Precise Trade Entry Recommendations - newser.com
Exit strategy if you’re trapped in Context Therapeutics Inc.July 2025 EndofMonth & Comprehensive Market Scan Insights - newser.com
What drives Context Therapeutics Inc stock priceEnergy Sector Updates & Small Budget Trading Ideas - earlytimes.in
Context Therapeutics (CNTX) Projected to Post Earnings on Wednesday - MarketBeat
Statistical indicators supporting Context Therapeutics Inc.’s strengthTake Profit & Weekly High Potential Alerts - newser.com
Context Therapeutics Inc. (NASDAQ:CNTX) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Step Pharma announces the appointment of Dr Karen Smith as Chief Medical Officer - GlobeNewswire Inc.
Context Therapeutics to Participate in Upcoming Investor Conferences - The Manila Times
Context Therapeutics (NASDAQ: CNTX) to join Guggenheim and Stifel investor conferences - Stock Titan
Context Therapeutics Inc Azioni (CNTX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Context Therapeutics Inc Azioni (CNTX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Levit Alex C. | Chief Legal Officer, Corp. Sec |
Jun 06 '25 |
Buy |
0.58 |
20,000 |
11,520 |
29,000 |
| Minai-Azary Jennifer Lynn | Chief Financial Officer |
Jun 06 '25 |
Buy |
0.64 |
40,010 |
25,486 |
80,010 |
1.62%
0.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):